Mark Cuban Cost Plus Drug Co. will sell Euthyrox, its 21st brand-name drug, in March.
Euthyrox (levothyroxine) is Provell Pharmaceuticals' FDA-approved treatment for hypothyroidism and pituitary thyrotropin in thyroid cancer patients. Mark Cuban's drug company also sells brand-name medications from Pfizer, Bayer and Johnson & Johnson.
The 20 other branded therapies Cost Plus Drugs offers:
- Advair Diskus (fluticasone/salmeterol)
- Brenzavvy (bexagliflozin)
- CaroSpir (spironolactone)
- Climara (estradiol)
- Clomid (clomiphene citrate)
- Dexamethasone Intensol (dexamethasone)
- Duavee (conjugated estrogens/bazedoxifene)
- Estring (estradiol)
- GaviLyte-C (PEG 3350-KCl-Na bicarb-NaCl-Na sulfate)
- Invokamet (canagliflozin-metformin HCl)
- Invokamet XR (canagliflozin-metformin HCl)
- Invokana (canagliflozin)
- Nitro-Bid (nitroglycerin)
- Premarin (conjugated estrogens)
- Premphase (conjugated estrogens/medroxyprogesterone)
- Prempro (conjugated estrogens/medroxyprogesterone)
- Promethegan (promethazine HCl)
- Tirosint (levothyroxine sodium)
- Yaz (drospirenone/ethinyl estradiol)
- Yusimry (adalimumab-aqvh)